We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PDSB PDS Biotechnology Corporation

-0.12 (-2.33%)
Pre Market
Last Updated: 04:47:08
Delayed by 15 minutes


Draw Mode:

Volume 1,000
Bid Price 5.15
Ask Price 5.45
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
PDS Biotechnology Corporation PDSB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.12 -2.33% 5.02 04:47:08
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
5 1,000 - 3.80 - 13.65
Last Trade Time Type Quantity Stock Price Currency
04:20:03 95 $ 5.02 USD

PDS Biotechnology Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
159.89M 31.11M - 0 -40.86M -1.31 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

PDS Biotechnology News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No PDSB Message Board. Create One! See More Posts on PDSB Message Board See More Message Board Posts

Historical PDSB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week6.186.455.0085.46519,594-1.16-18.77%
1 Month4.206.854.195.64638,5410.8219.52%
3 Months5.826.853.805.10487,596-0.80-13.75%
6 Months8.5610.273.805.75714,173-3.54-41.36%
1 Year8.0313.653.806.97620,258-3.01-37.48%
3 Years2.1317.852.02087.04743,1952.89135.68%
5 Years8.1617.850.615.81653,354-3.14-38.48%

PDS Biotechnology Description

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is primarily engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Your Recent History

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |